Australia markets closed

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.41-0.09 (-1.64%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 263.25M
Enterprise value 297.70M
Trailing P/E N/A
Forward P/E 48.31
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)65.02
Enterprise value/revenue 8.47k
Enterprise value/EBITDA -5.91

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 326.40%
S&P500 52-week change 320.07%
52-week high 311.00
52-week low 31.75
50-day moving average 36.46
200-day moving average 37.16

Share statistics

Avg vol (3-month) 329.73k
Avg vol (10-day) 3100.99k
Shares outstanding 547.11M
Implied shares outstanding 650.21M
Float 820.76M
% held by insiders 10.00%
% held by institutions 119.69%
Shares short (28 Mar 2024) 450.27k
Short ratio (28 Mar 2024) 46.02
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.11%
Shares short (prior month 29 Feb 2024) 443.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-770.60%

Management effectiveness

Return on assets (ttm)-47.69%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)6.74M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)147.80%
Gross profit (ttm)N/A
EBITDA -46.08M
Net income avi to common (ttm)-58.78M
Diluted EPS (ttm)-1.79
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.63M
Total cash per share (mrq)0.61
Total debt (mrq)54M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.68
Book value per share (mrq)-1.53

Cash flow statement

Operating cash flow (ttm)-36.86M
Levered free cash flow (ttm)-24.63M